Is COVID-19 Vaccination Beneficial for Tumor Patients: A Cross-Sectional Investigation in China.

ABSTRACT:

Introduction

Tumor patients take a high risk of SARS-CoV-2 infection, high incidence of serious events, poor prognosis and high mortality in the coronavirus disease 2019 (COVID-19) epidemic, but there is still lack of supporting evidence that the COVID-19 vaccination is beneficial for tumor patients to encourage them to receive the vaccination.

Methods

A cross-sectional study was conducted in Shantou, China and questionnaires were collected in the hospitals from February 13, 2023 to April 23, 2023. Using the receiving of COVID-19 vaccination as the primary outcome, descriptive, univariate and multivariate analyses were generated.

Results

161 out of 241 patients (66.80%) had received at least one dose of COVID-19 vaccine and 61.00% patients had been infected with SARS-

SUBMITTER: Wang S 

PROVIDER: S-EPMC11600451 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature